Finch Therapeutics Group, Inc.
FNCH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$74,754 | -$114,646 | -$58,160 |
| Dep. & Amort. | – | $1,520 | $5,507 | $2,301 |
| Deferred Tax | – | -$3,461 | $0 | -$1,836 |
| Stock-Based Comp. | – | $1,929 | $7,844 | $4,161 |
| Change in WC | – | -$5,420 | -$1,564 | -$14,512 |
| Other Non-Cash | – | $48,681 | $28,008 | $913 |
| Operating Cash Flow | – | -$31,505 | -$74,851 | -$67,133 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | $0 | -$2,182 | -$15,983 |
| Net Acquisitions | – | $0 | $0 | $62 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | $1,327 | $0 | $0 |
| Investing Cash Flow | – | $1,327 | -$2,182 | -$15,921 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | -$16,155 | $14,716 | -$27 |
| Stock Issued | – | $0 | $157 | $118,576 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $0 | $0 | $561 |
| Financing Cash Flow | – | -$16,155 | $14,873 | $119,110 |
| Forex Effect | – | $0 | $0 | $0 |
| Net Chg. in Cash | – | -$46,333 | -$62,160 | $36,056 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $73,805 | $135,965 | $99,909 |
| End Cash | – | $27,472 | $73,805 | $135,965 |
| Free Cash Flow | – | -$31,505 | -$77,033 | -$83,116 |